Department of Chemical Engineering, University of Michigan, Ann Arbor, Michigan, 48109, USA.
Department of Biomedical Engineering, University of Michigan, Ann Arbor, Michigan, 48109, USA.
Sci Rep. 2018 Feb 8;8(1):2671. doi: 10.1038/s41598-018-20966-1.
A major translational challenge in the fields of therapeutic angiogenesis and regenerative medicine is the need to create functional microvasculature. The purpose of this study was to assess whether a potentially autologous endothelial cell (EC) source derived from human induced pluripotent stem cells (iPSC-ECs) can form the same robust, stable microvasculature as previously documented for other sources of ECs. We utilized a well-established in vitro assay, in which endothelial cell-coated (iPSC-EC or HUVEC) beads were co-embedded with fibroblasts in a 3D fibrin matrix to assess their ability to form stable microvessels. iPSC-ECs exhibited a five-fold reduction in capillary network formation compared to HUVECs. Increasing matrix density reduced sprouting, although this effect was attenuated by distributing the NHLFs throughout the matrix. Inhibition of both MMP- and plasmin-mediated fibrinolysis was required to completely block sprouting of both HUVECs and iPSC-ECs. Further analysis revealed MMP-9 expression and activity were significantly lower in iPSC-EC/NHLF co-cultures than in HUVEC/NHLF co-cultures at later time points, which may account for the observed deficiencies in angiogenic sprouting of the iPSC-ECs. Collectively, these findings suggest fundamental differences in EC phenotypes must be better understood to enable the promise and potential of iPSC-ECs for clinical translation to be realized.
在治疗性血管生成和再生医学领域,一个主要的转化挑战是需要创建功能性微血管。本研究旨在评估源自人诱导多能干细胞(iPSC-EC)的潜在自体内皮细胞(EC)来源是否能够形成与以前报道的其他 EC 来源相同的稳健、稳定的微血管。我们利用了一种成熟的体外检测方法,其中内皮细胞包被的(iPSC-EC 或 HUVEC)珠与成纤维细胞共同嵌入在 3D 纤维蛋白基质中,以评估它们形成稳定微血管的能力。与 HUVEC 相比,iPSC-EC 的毛细血管网络形成减少了五倍。增加基质密度会减少发芽,但通过将 NHLF 分布在整个基质中,这种作用会减弱。需要同时抑制 MMP 和纤溶酶介导的纤维蛋白溶解,才能完全阻止 HUVEC 和 iPSC-EC 的发芽。进一步的分析表明,在稍后的时间点,iPSC-EC/NHLF 共培养物中的 MMP-9 表达和活性明显低于 HUVEC/NHLF 共培养物,这可能解释了 iPSC-EC 血管生成发芽的观察到的缺陷。总的来说,这些发现表明,必须更好地了解 EC 表型的基本差异,才能实现 iPSC-EC 用于临床转化的前景和潜力。